GEHC logo

GEHC EBITDA

annual EBITDA:

$3.67B+$153.00M(+4.36%)
December 31, 2024

Summary

  • As of today (June 22, 2025), GEHC annual EBITDA is $3.67 billion, with the most recent change of +$153.00 million (+4.36%) on December 31, 2024.
  • During the last 3 years, GEHC annual EBITDA has risen by +$126.00 million (+3.56%).
  • GEHC annual EBITDA is now at all-time high.

Performance

1-year change

+4.36%

3-year change

+3.56%

5-year change

+29.18%

15-year change

+29.18%

GEHC EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

97.74%
GEHC annual EBITDA is higher than 97.74% of companies in Healthcare sector

Range

All-time high

$3.67B
GEHC annual EBITDA is currently at an all-time high

3-year low

$3.23B
GEHC annual EBITDA is currently +13.46% above its 3-year low

Earnings dates

Last annual earnings report date

Dec 31, 2024
GEHC previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
GEHC next annual earnings announcement has not yet been scheduled

OtherGEHCincome statement metrics

Annual revenue

$19.67B
GEHC annual revenue is $19.67 billion

annual net income

$1.99B
GEHC annual net profit is $1.99 billion

annual EBIT

$3.09B
GEHC annual earnings before interest & taxes is $3.09 billion

Annual EPS

$4.34
GEHC annual earnings per share is $4.34

quarterly EBITDA:

$939.00M-$146.00M(-13.46%)
March 31, 2025

Summary

  • As of today (June 22, 2025), GEHC quarterly EBITDA is $939.00 million, with the most recent change of -$146.00 million (-13.46%) on March 31, 2025.
  • Over the past year, GEHC quarterly EBITDA has increased by +$141.00 million (+17.67%).
  • GEHC quarterly EBITDA is now -13.46% below its all-time high of $1.08 billion, reached on December 31, 2024.

Performance

3-month change

-13.46%

1-year change

+17.67%

3-year change

+34.53%

5-year change

+2.62%

GEHC quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

97.03%
GEHC quarterly EBITDA is higher than 97.03% of companies in Healthcare sector

Range

All-time high

$1.08B
GEHC quarterly EBITDA is currently -13.46% below its historical high of $1.08 billion

3-year low

$784.00M
GEHC quarterly EBITDA is currently +19.77% above its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
GEHC previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Jul 31, 2025
GEHC next earnings announcement is scheduled for Jul 31, 2025

OtherGEHCincome statement metrics

Quarterly revenue

$4.78B
GEHC quarterly revenue is $4.78 billion

quarterly net income

$564.00M
GEHC quarterly net profit is $564.00 million

quarterly EBIT

$803.00M
GEHC quarterly earnings before interest & taxes is $803.00 million

Quarterly EPS

$1.23
GEHC quarterly earnings per share is $1.23

TTM EBITDA:

$3.81B+$141.00M(+3.84%)
March 31, 2025

Summary

  • As of today (June 22, 2025), GEHC TTM EBITDA is $3.81 billion, with the most recent change of +$141.00 million (+3.84%) on March 31, 2025.
  • Over the past year, GEHC TTM EBITDA has increased by +$341.00 million (+9.82%).
  • GEHC TTM EBITDA is now at all-time high.

Performance

3-month change

+3.84%

1-year change

+9.82%

3-year change

+136.39%

5-year change

+316.72%

GEHC TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

97.29%
GEHC TTM EBITDA is higher than 97.29% of companies in Healthcare sector

Range

All-time high

$3.81B
GEHC TTM EBITDA is currently at an all-time high

3-year low

$2.43B
GEHC TTM EBITDA is currently +56.85% above its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
GEHC previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Jul 31, 2025
GEHC next earnings announcement is scheduled for Jul 31, 2025

OtherGEHCincome statement metrics

TTM revenue

$19.80B
GEHC TTM revenue is $19.80 billion

TTM net income

$2.18B
GEHC TTM net profit is $2.18 billion

TTM EBIT

$3.25B
GEHC TTM earnings before interest & taxes is $3.25 billion

TTM EPS

$4.75
GEHC TTM earnings per share is $4.75

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

annual EBITDA

$3.67B
GEHC annual EBITDA is $3.67 billion

annual net income

$1.99B
GEHC annual net profit is $1.99 billion

annual interest expense

$505.00M
GEHC annual interest expense is $505.00 million

annual income tax

$531.00M
GEHC annual income tax is $531.00 million

annual D&A

$580.00M
GEHC annual depreciation & amortization is $580.00 million

GEHC EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+4.4%+17.7%+9.8%
3 y3 years+3.6%+34.5%+136.4%
5 y5 years+29.2%+2.6%+316.7%

GEHC EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+13.5%-13.5%+19.8%at high+56.9%
5 y5-yearat high+29.2%-13.5%+34.5%at high+316.7%
alltimeall timeat high+29.2%-13.5%+34.5%at high+316.7%

GEHC EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
$939.00M(-13.5%)
$3.81B(+3.8%)
Dec 2024
$3.67B(+4.4%)
$1.08B(+16.5%)
$3.67B(+5.8%)
Sep 2024
-
$931.00M(+8.5%)
$3.47B(+0.1%)
Jun 2024
-
$858.00M(+7.5%)
$3.47B(-0.1%)
Mar 2024
-
$798.00M(-9.7%)
$3.47B(-1.2%)
Dec 2023
$3.51B
$884.00M(-4.6%)
$3.51B(-1.4%)
Sep 2023
-
$927.00M(+7.4%)
$3.56B(+4.2%)
Jun 2023
-
$863.00M(+2.9%)
$3.42B(+1.3%)
DateAnnualQuarterlyTTM
Mar 2023
-
$839.00M(-10.3%)
$3.38B(+4.4%)
Dec 2022
$3.23B(-8.7%)
$935.00M(+19.3%)
$3.23B(+0.6%)
Sep 2022
-
$784.00M(-4.2%)
$3.21B(+32.3%)
Jun 2022
-
$818.00M(+17.2%)
$2.43B(+50.7%)
Mar 2022
-
$698.00M(-23.7%)
$1.61B(+76.3%)
Dec 2021
$3.54B(+3.9%)
-
-
Dec 2021
-
$915.00M
$915.00M
Dec 2020
$3.41B(+20.0%)
-
-
Dec 2019
$2.84B
-
-

FAQ

  • What is GE HealthCare Technologies annual EBITDA?
  • What is the all time high annual EBITDA for GE HealthCare Technologies?
  • What is GE HealthCare Technologies annual EBITDA year-on-year change?
  • What is GE HealthCare Technologies quarterly EBITDA?
  • What is the all time high quarterly EBITDA for GE HealthCare Technologies?
  • What is GE HealthCare Technologies quarterly EBITDA year-on-year change?
  • What is GE HealthCare Technologies TTM EBITDA?
  • What is the all time high TTM EBITDA for GE HealthCare Technologies?
  • What is GE HealthCare Technologies TTM EBITDA year-on-year change?

What is GE HealthCare Technologies annual EBITDA?

The current annual EBITDA of GEHC is $3.67B

What is the all time high annual EBITDA for GE HealthCare Technologies?

GE HealthCare Technologies all-time high annual EBITDA is $3.67B

What is GE HealthCare Technologies annual EBITDA year-on-year change?

Over the past year, GEHC annual EBITDA has changed by +$153.00M (+4.36%)

What is GE HealthCare Technologies quarterly EBITDA?

The current quarterly EBITDA of GEHC is $939.00M

What is the all time high quarterly EBITDA for GE HealthCare Technologies?

GE HealthCare Technologies all-time high quarterly EBITDA is $1.08B

What is GE HealthCare Technologies quarterly EBITDA year-on-year change?

Over the past year, GEHC quarterly EBITDA has changed by +$141.00M (+17.67%)

What is GE HealthCare Technologies TTM EBITDA?

The current TTM EBITDA of GEHC is $3.81B

What is the all time high TTM EBITDA for GE HealthCare Technologies?

GE HealthCare Technologies all-time high TTM EBITDA is $3.81B

What is GE HealthCare Technologies TTM EBITDA year-on-year change?

Over the past year, GEHC TTM EBITDA has changed by +$341.00M (+9.82%)
On this page